您的位置: 首页 > 文字全文
2023年7月 第38卷 第7期11
目录

浅析乳腺癌化疗后骨髓抑制的中医研究进展

浅析乳腺癌化疗后骨髓抑制的中医研究进展

来源期刊: 广州医药 | - 发布时间: 收稿时间:2026/6/16 18:21:58 阅读量:0
作者:
关键词:
乳腺癌;化疗后骨髓抑制;中医药治疗;研究进展
Breast cancer; Bone marrow suppression after chemotherapy; Traditional Chinese Medicine Treatment; Research Progress
DOI:
收稿时间:
 
修订日期:
 
接收日期:
 
引用总数:
0  
乳腺癌化疗后骨髓抑制是临床常见不良反应,严重影响治疗依从性与疗效。中医药已形成系统防治体系,以“脾肾亏虚、气血不足”为核心病机,构建内治外治结合的诊疗模式。内治采用汤剂、中成药等,以健脾补肾、益气养血为法;外治依据经络理论,运用针刺、艾灸等手段,实现协同增效。本文梳理中医药治疗的理论与研究进展,旨在为临床应用与后续研究提供参考。
Bone marrow suppression after chemotherapy for breast cancer is a common clinical adverse reaction, which seriously affects the treatment compliance and efficacy. Traditional Chinese medicine has formed a systematic prevention and treatment system, with "spleen and kidney deficiency, qi and blood deficiency" as the core pathogenesis, and a diagnosis and treatment model that combines internal and external treatment. Internal treatment adopts decoction, traditional Chinese patent medicines and simple preparations, etc., with the method of strengthening spleen and kidney, supplementing qi and nourishing blood; External treatment is based on the theory of meridians, using acupuncture, moxibustion and other methods to achieve synergistic effects. This article reviews the theory and research progress of traditional Chinese medicine treatment, aiming to provide reference for clinical application and subsequent research.
1、吉林省教育厅科学技术研究项目(/upload/408315/20260616/20260616182124_3527.pdf)
上一篇
下一篇
出版者信息








《广州医药》公众号
目录